Teleflex Incorporated (TFX) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Total Assets Chart for Teleflex Incorporated
Teleflex Incorporated (TFX) total assets for FY2025 were USD 6.9B, a -2.1% change from FY2024. Teleflex Incorporated's total assets grew from USD 136.9M in 1985 to USD 6.9B in 2025 (4974.7% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -0.6%, 10-year CAGR of 6.0%, 20-year CAGR of 5.2%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.77B
- Implied Share Price
- $136.29
- Enterprise Value
- $7.86B
- Revenue (TTM)
- $2.25B
- EBITDA
- $403.90M
- Profit Margin
- -45.76%
- Trailing P/E
- —
- Forward P/E
- 11.01
- Price/Book (MRQ)
- 1.82
- Price/Sales (TTM)
- 2.56
- EV/EBITDA
- 30.73
- EV/Revenue
- 3.49
- Dividend Yield
- 1.00%
- Book Value
- $68.55
- Free Cash Flow (FY2025)
- $245.44M
- Free Cash Flow Yield
- 4.25%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.